Weight Loss Drugs and Their Impact on Psoriatic Arthritis

This chapter explores recent advancements in psoriatic arthritis treatments, emphasizing the role of weight loss drugs like SGL2 and GLP1. It examines their impact on disease management, especially for patients with metabolic syndrome, and raises concerns regarding the sustainability of benefits post-medication.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app